Cra International (CR2) AI Stock Analysis

1 Followers

Cra International

(Frankfurt:CR2)

Rating:―N/A

Action:N/A

Date:―

No summary available

Positive Factors

Broad-based revenue growthGrowth is diversified across most of CRAI’s revenue base rather than concentrated in one practice. Double-digit expansion in Forensic Services, Life Sciences and Risk, Investigations & Analytics, alongside legal and management consulting growth, supports more durable demand.

Negative Factors

Weak cash generationThe sharp deterioration in operating and free cash flow weakens the conversion of reported earnings into financial resources. If sustained, this can constrain reinvestment, shareholder returns and debt reduction while increasing exposure to working-capital volatility.

Cra International (CR2) vs. iShares MSCI Germany ETF (EWG)

Market Cap: EUR 1.26B
Dividend Yield: 1.13%
Average Volume (3M): ―
Price to Earnings (P/E): 24.8
Beta (1Y): 0.07
Revenue Growth: 7.10%
EPS Growth: -9.63%
Country: Germany
Employees: 968
Sector: Industrials
Sector Strength: 63
Industry: Consulting Services

Cra International Business Overview & Revenue Model

Company Description

CRA International, Inc., along with its affiliated entities, delivers specialized advisory services across the domains of economics, finance, and management in the United States, the United Kingdom, and globally. The firm provides expert guidance to...

Cra International Earnings Call Summary

Earnings Call Date:Nov 05, 2026(Q3-2026)|% Change Since:1.17%|Next Earnings Date:Mar 04, 2027

Earnings Call SentimentPositive

The call was strongly positive overall. CRA reported record quarterly and year-to-date revenue and profitability, broad-based practice growth, more than 20% growth in lead flow and project originations, increased guidance, strong liquidity and continued shareholder returns. The company also cited challenges including a 41% sequential decline in global M&A activity, a higher tax rate, increased amortization expense, higher DSO, foreign-exchange impacts and ongoing macroeconomic and political uncertainty, but these issues did not outweigh the reported operating momentum.

Positive Updates

Record Quarterly Revenue and Profitability

Third-quarter revenue grew 15.6% year-over-year to $214.9 million, the highest quarterly revenue in CRA's history. Fiscal 2026 has delivered the three highest revenue quarters in the company's history, and Q3 also produced record net income, earnings per diluted share and EBITDA.

Negative Updates

Sequential Decline in Global M&A Activity

Although worldwide M&A activity totaled $3.9 trillion in the first nine months of 2026, up 28% from the prior year and the strongest first three quarters since 2021, third-quarter activity was $993 billion, down 41% from the second quarter and the slowest quarter by value since Q2 2025.

Company Guidance

For full year fiscal 2026, on a constant currency basis relative to fiscal 2025, CRA expects revenue in the range of $830 million to $840 million and non-GAAP EBITDA margin in the range of 12.2% to 12.8%, compared with the prior revenue range of $805 million to $820 million and a prior non-GAAP EBITDA margin range of 12.0% to 13.0%; the constant currency adjustment is expected to decrease CRA's reported revenue by approximately $2.9 million and CRA's reported annual EBITDA by approximately $350,000, including approximately $200,000 of reported revenue impact in the fourth quarter while leaving reported EBITDA unchanged, and noncash forgivable loan amortization is expected to increase in fiscal 2026 by approximately $15 million, including an increase of approximately $1 million during the fourth quarter of fiscal 2026 relative to the fourth quarter of fiscal 2025. Headcount growth for fiscal 2026 will approach mid-single digits; management would not expect or guide investors to the high single digits and is comfortable with the mid-single-digit range.

Cra International Risk Analysis

Cra International disclosed 31 risk factors in its most recent earnings report. Cra International reported the most risks in the "Finance & Corporate" category.

Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy

Latest Risks Added

0 New Risks

Cra International Peers Comparison

Overall Rating

UnderperformOutperform

Sector (63)

Financial Indicators

DE:CR2 against its peers
Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
ICFI	73Outperform	$1.49B	15.50	9.20%	0.68%	-5.16%	-0.04%
HURN	70Outperform	$2.63B	24.55	26.67%	―	12.30%	11.07%
BAH	68Neutral	$10.37B	13.43	68.53%	2.72%	-6.19%	-1.80%
FCN	64Neutral	$5.38B	24.87	15.43%	―	7.77%	1.87%
Sector *	63Neutral	$10.79B	15.43	7.44%	2.01%	2.89%	-14.66%
FORR	42Neutral	$159.70M	-3.83	-38.73%	―	-7.68%	47.26%

* Industrials Sector Average

Performance Comparison

DE:CR2 and its peers over the selected period
Ticker	Company Name	Price	Change	% Change
DE:CR2	CRA International	173.00	22.10	14.65%
BAH	Booz Allen Hamilton Holding	86.89	5.11	6.24%
FORR	Forrester Research	9.04	1.21	15.39%
FCN	FTI Consulting	197.21	32.25	19.55%
HURN	Huron Consulting Group	168.16	6.39	3.95%
ICFI	Icf International	82.77	4.11	5.23%

Glossary

BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.

Cra International AI Stock Analysis